Notes
The study was supported by an unrestricted grant from Johnson & Johnson Medical (China) Ltd.
Reference
Du X, et al. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs : 14 May 2019. Available from: URL: http://doi.org/10.1007/s40256-019-00349-1
Rights and permissions
About this article
Cite this article
Radiofrequency catheter ablation in AF worth its cost in China. PharmacoEcon Outcomes News 829, 24 (2019). https://doi.org/10.1007/s40274-019-5938-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5938-y